FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martti Ala-Opas

Research Profile

Disorders

Procedures

Geographic Areas

Finland

Concepts & Ideas

Chemicals & Drugs

Physiology

Urodynamics

Co-author Network

Publications

TOP 3
Arto J Salonen; Kimmo Taari; Teuvo L J Tammela; J Viitanen; Martti Ala-Opas; Seppo Lundstedt
Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.
Arto J Salonen; Kimmo Taari; Teuvo L J Tammela; J Viitanen; Martti Ala-Opas; Seppo Lundstedt
The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.
Teemu J Murtola; Teuvo L J Tammela; Liisa Määttänen; Heini Huhtala; Elizabeth A Platz; Martti Ala-Opas; Ulf-Håkan Stenman; Anssi Auvinen
Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martti Ala-Opas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arto J Salonen; Kimmo Taari; Teuvo L J Tammela; J Viitanen; Martti Ala-Opas; Seppo Lundstedt
Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.
European urology 2013;63(1):111-20.
2012: Arto J Salonen; Kimmo Taari; Teuvo L J Tammela; J Viitanen; Martti Ala-Opas; Seppo Lundstedt
The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.
The Journal of urology 2012;187(6):2074-81.
2010: Teemu J Murtola; Teuvo L J Tammela; Liisa Määttänen; Heini Huhtala; Elizabeth A Platz; Martti Ala-Opas; Ulf-Håkan Stenman; Anssi Auvinen
Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
International journal of cancer. Journal international du cancer 2010;127(7):1650-9.
2010: Harri Visapää; Kristina Hotakainen; Johan Lundin; Martti Ala-Opas; Ulf-Håkan Stenman
The proportion of free PSA and upgrading of biopsy Gleason score after radical prostatectomy.
Urologia internationalis 2010;84(4):378-81.
2009: Marita Laurila; Teuvo L J Tammela; Anssi Auvinen; Jorma Isola; Tapio Visakorpi; Tiina Luukkaala; Liisa Määttänen; Mirja Ruutu; Martti Ala-Opas; Markus Mildh; Paula Martikainen
Biological aggressiveness of prostate cancer in the Finnish screening trial.
International journal of cancer. Journal international du cancer 2009;124(3):547-52.
2008: Arto J Salonen; J Viitanen; Seppo Lundstedt; Martti Ala-Opas; Kimmo Taari; Teuvo L J Tammela
Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.
The Journal of urology 2008;180(3):915-9; discussion 919-20.
2008: Harry Nisen; Ilkka Perttilä; Tuula Ranta-Knuuttila; Martti Ala-Opas; Anna Sankila; Kimmo Taari
Laparoscopic radical prostatectomy: surgical, oncological and functional outcomes.
Scandinavian journal of urology and nephrology 2008;42(1):29-34.
2007: Kilian Guse; Tuuli Ranki; Martti Ala-Opas; Petri Bono; Merja Särkioja; Maria Rajecki; Anna Kanerva; Tanja Hakkarainen; Akseli Hemminki
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses.
Molecular cancer therapeutics 2007;6(10):2728-36.
2007: Maria Rajecki; Anna Kanerva; Ulf-Hakan Stenman; Mikko Tenhunen; Lotta Kangasniemi; Merja Särkioja; Martti Ala-Opas; Henrik Alfthan; Anna Sankila; Erkki Rintala; Renee A Desmond; Tanja Hakkarainen; Akseli Hemminki
Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo.
Molecular cancer therapeutics 2007;6(2):742-51.
2007: Liisa Määttänen; Matti Hakama; Teuvo L J Tammela; Mirja Ruutu; Martti Ala-Opas; Harri Juusela; P Martikainen; Ulf-Hakan Stenman; Anssi Auvinen
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
British journal of cancer 2007;96(1):56-60.
2006: Harry Nisen; Ilkka Perttilä; Harri Juusela; Martti Ala-Opas; Kimmo Taari
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2006;122(10):1182-7.
2004: Antti Dahlberg; Ilkka Perttilä; E Wuokko; Martti Ala-Opas
Bladder management in persons with spinal cord lesion.
Spinal cord 2004;42(12):694-8.
2004: Kari Tuhkanen; Antero Heino; Sirpa Aaltoma; Martti Ala-Opas
Sexual function of LUTS patients before and after neodymium laser prostatectomy and transurethral resection of prostate. A prospective, randomized trial.
Urologia internationalis 2004;73(2):137-42.
2003: Patrik Finne; Ulf-Hakan Stenman; Liisa Määttänen; Tuukka Mäkinen; Teuvo L J Tammela; P Martikainen; Mirja Ruutu; Martti Ala-Opas; Jussi Aro; Pekka J Karhunen; Jorma Lahtela; Pekka Rissanen; Harri Juusela; Matti Hakama; Anssi Auvinen
The Finnish trial of prostate cancer screening: where are we now?
BJU international 2003;92 Suppl 2():22-6.
2003: S Grönlund-Pakkanen; Jarmo Wahlfors; Martti Talja; V-M Kosma; Timo M Pakkanen; Martti Ala-Opas; Esko Alhava; R B Moore
The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
BJU international 2003;92(1):125-30.
2003: Kari Tuhkanen; Antero Heino; Sirpa Aaltomaa; Martti Ala-Opas
Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Scandinavian journal of urology and nephrology 2003;37(6):487-93.
2002: Mazen Sudah; Ritva Vanninen; Kaarina Partanen; Sakari Kainulainen; Auli Malinen; Antero Heino; Martti Ala-Opas
Patients with acute flank pain: comparison of MR urography with unenhanced helical CT.
Radiology 2002;223(1):98-105.
2002: Sari Gronlund-Pakkanen; Jarmo Wahlfors; Kimmo Makinen; Timo M Pakkanen; Martti Talja; Martti Ala-Opas; Esko Alhava; Ronald B Moore
The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
The Journal of urology 2002;167(4):1848-53.
2002: Per Olov Hedlund; Martti Ala-Opas; Einar Brekkan; Jan-Erik Damber; Lena Damber; Inger Hagerman; Svein Haukaas; Peter Henriksson; Peter Iversen; Ake Pousette; Finn Rasmussen; Jaakko Salo; Sigmund Vaage; Eberhard Varenhorst
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
Scandinavian journal of urology and nephrology 2002;36(6):405-13.
2001: Kalevi Juhani Pulkkanen; Jyrki Parkkinen; J M Laukkanen; Mikko I Kettunen; K Tyynela; Risto A Kauppinen; Martti Ala-Opas; Seppo Yla-Herttuala
HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Cancer gene therapy 2001;8(7):529-36.
2001: Kari Tuhkanen; Antero Heino; Martti Ala-Opas
Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates.
Scandinavian journal of urology and nephrology 2001;35(3):200-4.
2001: S Grönlund-Pakkanen; Timo M Pakkanen; E M J Koski; Martti Talja; Martti Ala-Opas; Esko Alhava
Effect of photodynamic therapy on urinary bladder function: an experimental study with rats.
Urological research 2001;29(3):205-9.
2001: Sirpa Aaltomaa; Martti Ala-Opas
The effect of transurethral needle ablation on symptoms of chronic pelvic pain syndrome--a pilot study.
Scandinavian journal of urology and nephrology 2001;35(2):127-31.
2001: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Veli-Matti Kosma
Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
European urology 2001;39(2):138-44.
2001: Mazen Sudah; Ritva Vanninen; Kaarina Partanen; Antero Heino; Pauli Vainio; Martti Ala-Opas
MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shot.
AJR. American journal of roentgenology 2001;176(1):105-12.
2000: Sirpa Aaltomaa; Pertti Lipponen; J Viitanen; JP Kankkunen; Martti Ala-Opas; Veli-Matti Kosma
Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
European urology 2000;38(5):555-62.
2000: Tapani Liukkonen; Pertti Lipponen; Mika Raitanen; Eero Kaasinen; Martti Ala-Opas; Pertti Rajala; V M Kosma
Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.
Urological research 2000;28(5):285-92.
2000: J Lumiaho; Antero Heino; T Pietiläinen; Martti Ala-Opas; Martti Talja; Tero Välimaa; Pertti Törmälä
The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA 96) ureteric stent; an experimental study.
The Journal of urology 2000;164(4):1360-3.
2000: Sirpa Aaltomaa; Pertti Lipponen; J Viitanen; JP Kankkunen; Martti Ala-Opas; V M Kosma
The prognostic value of inducible nitric oxide synthase in local prostate cancer.
BJU international 2000;86(3):234-9.
2000: S Grönlund-Pakkanen; Timo M Pakkanen; Martti Talja; V M Kosma; Martti Ala-Opas; Esko Alhava
The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX.
BJU international 2000;86(1):126-32.
2000: Kalevi Juhani Pulkkanen; J J Parkkinen; M I Kettunen; Risto A Kauppinen; M Lappalainen; Martti Ala-Opas; Seppo Yla-Herttuala
Characterization of a new animal model for human renal cell carcinoma.
In vivo (Athens, Greece) 2000;14(3):393-400.
2000: Pertti Lipponen; Sirpa Aaltomaa; Jari K Kellokoski; Martti Ala-Opas; Veli-Matti Kosma
Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation.
European urology 2000;37(5):573-8.
1999: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen; Veli-Matti Kosma
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
British journal of cancer 1999;80(12):2001-7.
1999: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Matti Eskelinen; Veli-Matti Kosma
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
British journal of cancer 1999;80(3-4):477-82.
1999: Sirpa Aaltomaa; Pertti Lipponen; Matti Eskelinen; Martti Ala-Opas; V M Kosma
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.
The Prostate 1999;39(1):8-15.
1999: J Lumiaho; Antero Heino; V Tunninen; Martti Ala-Opas; Martti Talja; Tero Välimaa; Pertti Törmälä
New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental study.
Journal of endourology / Endourological Society 1999;13(2):107-12.
1999: Kari Tuhkanen; Antero Heino; Martti Ala-Opas
Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six-month follow-up with complex urodynamic assessment.
Scandinavian journal of urology and nephrology 1999;33(1):31-4.
1999: Antero Heino; Sirpa Aaltomaa; Martti Ala-Opas
BTA test is superior to voided urine cytology in detecting malignant bladder tumours.
Annales chirurgiae et gynaecologiae 1999;88(4):304-7.
1998: Pertti Lipponen; Sirpa Aaltoma; Veli-Matti Kosma; Martti Ala-Opas; Matti Eskelinen
Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
The Journal of pathology 1998;186(2):157-64.
1998: Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Martti Ala-Opas; Veli-Matti Kosma
Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
European urology 1998;34(3):237-43.
1997: Sirpa Aaltomaa; Pertti Lipponen; S Vesalainen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
European urology 1997;32(4):410-5.
1997: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen
Prognostic value of Ki-67 expression in renal cell carcinomas.
European urology 1997;31(3):350-5.
1996: Pertti Lipponen; S Vesalainen; J Kasurinen; Martti Ala-Opas; Kari Syrjänen
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Anticancer research 1996;16(4A):2095-100.
1993: Martti Ala-Opas; Martti Talja; J Tiitinen; Pekka Hellström; A Heikkinen; Martti Nurmi
Prostakath in urinary outflow obstruction.
Annales chirurgiae et gynaecologiae. Supplementum 1993;206():14-8.